News from the financial sector on July 5 This evening's important announcement sneak peek - the second shareholder of Tongji Technology canceled the extraordinary shareholders' meeting; Yunnan germanium industry: the main products of material grade germanium products are mainly regional molten germanium ingots and germanium dioxide; Guangzhi Technology: For the time being, it is impossible to judge the impact of export control matters on the company...
【Major Matters】
The second shareholder of Tongji Technology canceled the extraordinary general meeting
Tongji Technology announced that the second shareholder, Quanting Industry, decided to cancel the extraordinary shareholders' meeting originally scheduled for July 7. Quanting Industrial said: In view of the fact that 17 motions including the "2023 Annual Investment Plan" and "2023 Annual Financial Budget Report" were not passed at the annual shareholders' meeting of Tongji Technology held on June 28, as the convener of this extraordinary shareholders' meeting, from the perspective of maintaining the operating environment of listed companies and safeguarding the interests of all shareholders, it was decided to cancel the convening of this extraordinary shareholders' meeting in advance. In the later stage, Quanting Industrial will have further in-depth communication with the major shareholders and actual controllers of the listed company, and strive to reach a plan acceptable to all parties and benefit the listed company as soon as possible.
DMS: The company's three products are used in industrial robot reducers
DMS disclosed the announcement of abnormal fluctuations in stock trading, the company's 3 products are used in industrial robot reducers, the customer has designated DMS production, is in the sample stage, currently has not formed operating income, no orders in hand.
Yunnan germanium industry: the main products of material grade germanium products are mainly regional molten germanium ingots and germanium dioxide
Yunnan germanium industry disclosed the announcement of abnormal fluctuations in stock trading, at present, the company's and subsidiaries' main products in material grade germanium products are mainly regional molten germanium ingots, germanium dioxide, photovoltaic grade germanium products are mainly solar germanium wafers, infrared grade germanium products are mainly infrared grade germanium single crystal (optical components), germanium lenses, lenses, infrared thermal imaging cameras, optical fiber grade germanium products are germanium tetrachloride for optical fibers, compound semiconductor materials are mainly gallium arsenide wafers, indium phosphide wafers. When it comes to products of the relevant categories announced by the Ministry of Commerce and the General Administration of Customs, the company and its subsidiaries must obtain a license in accordance with national laws and regulations and the provisions of the announcement before exporting.
Guangzhi Technology: For the time being, it is impossible to judge the impact of export control matters on the company
Guangzhi Technology disclosed the announcement of stock trading changes, the company's holding company Anhui Guangzhi Technology Co., Ltd. is mainly engaged in infrared optical materials and laser device business, infrared optical materials business involves products mainly for various germanium products (germanium dioxide, germanium tetrachloride, zone molten germanium, lenses, etc.), zinc selenide products and infrared lenses. The control announcement shows that the company's germanium dioxide, germanium tetrachloride, regional molten germanium and other products belong to the phase of substances (collectively referred to as dual-use items) that are subject to export control. In 2022, the overseas sales revenue of the company's above-mentioned dual-use items will be about 82.73 million yuan, accounting for 8.84% of the company's operating income. The Company is temporarily unable to judge the impact of the above matters on the Company.
【M&A and restructuring】
Yu Rural Commercial Bank: Approved to issue financial bonds
Yu Rural Commercial Bank announced that it recently received the "Decision on Granting Administrative License" from the People's Bank of China, and the Bank was allowed to issue financial bonds in the national interbank market and overseas markets, with the new balance of financial bonds not exceeding 6 billion yuan in 2023 and the balance of financial bonds not exceeding 39 billion yuan at the end of the year.
Xunjiexing: Plans to issue convertible bonds to raise no more than 340 million yuan
Xunjiexing announced that it intends to issue convertible bonds to raise no more than 340 million yuan for the Zhuhai Xunjiexing intelligent model production base project (phase I) and supplementary working capital.
Nanda Optoelectronics: Plans to purchase 16.5398% equity of Quanjiao Nanda
Nanda Optoelectronics announced that it intends to purchase 16.5398% of the equity of Quanjiao Nanda held by Nansheng No. 1 by issuing shares and paying cash, and after the completion of this transaction, the listed company will directly hold 100% of the equity of Quanjiao Nanda.
Guanghong Technology: intends to participate in the subscription of shares of Huaqin Technology's initial public offering
Guanghong Technology announced that it intends to use its own funds of no more than 50 million yuan as a strategic placement investor to participate in the subscription of shares of Huaqin Technology's initial public offering on the Shanghai Stock Exchange.
Yongtai Technology: The GDR price of this offering is expected to be no less than $9.41 per copy
Yongtai Technology announced that each global depositary receipt ("GDR") issued by the company represents 5 A shares of the company's underlying securities, the total amount of funds to be raised is capped at approximately US$100 million, and the price of the GDR issued in this offering is expected to be not less than US$9.41 per share. There is no over-allotment option in this offering.
Midland New Materials: Plans to issue convertible bonds to raise no more than 1 billion yuan
Midland New Materials announced that it intends to issue convertible bonds to raise no more than 1 billion yuan for Midland new energy and polymer materials industrialization construction project (phase I) and replenish working capital.
【Performance Forecast】
COSCO Haite: net profit in the first half of the year increased by 91.66% year-on-year
COSCO Haite released a half-year performance report, achieving a total operating income of 5.866 billion yuan in the first half of 2023, a year-on-year increase of 0.9%; The net profit attributable to shareholders of the listed company was 643 million yuan, a year-on-year increase of 91.66%. During the reporting period, the company's shipping operating efficiency maintained overall stability.
Lansheng shares: net profit is expected to be 190 million yuan in the first half of the year
Lansheng Co., Ltd. announced that it is expected that the net profit in the first half of the year will be 190 million yuan, turning losses into profits; the exhibition business in this period has fully recovered, and the indicators of the main business are better than the same period of the previous year.
Tianshun Wind Energy: net profit in the first half of the year increased by 105%-136% year-on-year
Tianshun Wind Energy announced that it is expected to have a net profit of 520 million yuan to 600 million yuan in the first half of the year, a year-on-year increase of 104.72% to 136.22%; During the reporting period, new offshore wind power pile foundation business was added, the delivery volume of onshore towers and blades increased compared with the same period of the previous year, and the scale of grid connection of wind farms and power generation business increased compared with the same period of the previous year.
Pinggao Electric: Net profit in the first half of the year increased by about 185% year-on-year
Pinggao Electric released a half-year performance forecast, and it is expected that the net profit attributable to the owner of the parent company in the half year of 2023 will be about 332 million yuan, a year-on-year increase of about 185%. During the reporting period, the industry developed well, the speed of power grid construction accelerated, the company increased market development efforts, executable projects were successively delivered, and operating income increased year-on-year.
Jiejia Vista: net profit in the first half of the year increased by 45%–60%
Jiejia Weichuang disclosed the half-year performance forecast, the company expects the net profit in the first half of the year to be 736 million yuan - 812 million yuan, a year-on-year increase of 45% - 60%. During the reporting period, the year-on-year growth of the company's net profit was mainly due to good market conditions and good market demand for the company's products, thereby promoting the growth of sales orders and the increase in sales revenue; Increase in VAT refundable revenue for software products.
Dongyue Silicon: It is expected that the net loss in the first half of the year will be 173 million yuan to 210 million yuan
Dongyue silicon announced that it is expected to have a net loss of 173 million yuan to 210 million yuan in the first half of the year, and a net profit of 520 million yuan in the same period last year; in the first half of the year, the global economic growth slowed down, commodity prices fell as a whole, at the same time, the domestic silicone new production capacity was fully released, the short-term imbalance between supply and demand, the price continued to decline, and the price of silicone DMC fell below the industry cost line.
Chongqing Department Store: net profit in the first half of the year increased by 51% to 65%
Chongqing Department Store announced that the company expects to achieve a net profit attributable to shareholders of listed companies of 890 million yuan to 970 million yuan in the half year of 2023, an increase of 51.43% to 65.05% year-on-year. In the first half of the year, the company's business development continued to improve, and its performance maintained good growth.
Changgao Denxin: net profit in the first half of the year increased by 63.35%-86.68%
Changgao Electric newly released a performance forecast, and it is expected that the net profit attributable to the parent in the half year of 2023 will be 84 million yuan to 96 million yuan, a year-on-year increase of 63.35% to 86.68%. During the reporting period, the company's power transmission and transformation equipment shipments increased year-on-year, and operating income increased year-on-year.
Jieshun Technology: Advance profit of 25 million yuan - 35 million yuan in the first half of the year
Jieshun Technology announced that it is expected that the net profit in the first half of the year will be 25 million yuan to 35 million yuan, and the loss in the same period last year will be 38.6677 million yuan. In the first half of the year, new businesses including parking lot cloud hosting SaaS business, Jie parking smart parking operation business, parking lot digital operation business, charging business and other new businesses achieved a high growth rate, driving the company's overall operating income growth; At the same time, the traditional smart hardware business resumed its growth trend.
Lu Chang Technology: In the first half of the year, the loss was 10 million yuan to 15 million yuan, and the loss was turned year-on-year
Lu Chang Technology released a performance forecast, and it is expected that the net profit loss attributable to the parent in the half year of 2023 will be 10 million yuan to 15 million yuan, and the profit in the same period of the previous year will be 2.7186 million yuan. During the reporting period, according to the work progress of each intermediary in the major asset restructuring project, the company made provision for intermediary expenses related to the enterprise merger, and increased the management expenses by 6.57 million yuan; Nanyang Changfeng New Material Technology Co., Ltd., a wholly-owned subsidiary, continued to decline in selling prices due to the downturn in the downstream market, resulting in a decline in gross profit margin and a decline in net profit; The company increased investment in the research and development of automotive electronic products, and the research and development expenses increased.
Changsheng Bearing: net profit in the first half of the year increased by 42%-67%
Changsheng Bearing announced that it is expected that the net profit attributable to the parent in the half year of 2023 will be 110 million yuan to 130 million yuan, a year-on-year increase of 42%-67%. In the first half of the year, the company's product structure changed, and the proportion of high gross profit products increased; The price of the main raw materials of the product decreased and remained stable, and the price adjustment mechanism was smoothly implemented; The exchange rate change has enabled the company to achieve a certain exchange gain.
【Overweight and reduction】
Wanfu Biotech: Plans to repurchase shares for 30 million yuan to 50 million yuan
Wanfu Biotech announced that the company intends to use its own funds to repurchase the company's shares in a centralized bidding transaction for the implementation of the company's subsequent employee stock ownership plan or equity incentives. The total amount of repurchase funds shall not be less than 30 million yuan and not more than 50 million yuan, and the repurchase price shall not exceed 43.06 yuan per share.
Guizhou Sanli: The controlling shareholder and the concerted actor intend to reduce their holdings of no more than 12.1% of the company's shares
Guizhou Sanli announced that Zhang Hai, the controlling shareholder and actual controller, and Wang Huiying and Ling Zongrong formed a concerted action relationship, holding a total of 59.688% of the company's shares, and intends to reduce their total holdings of no more than 12.097% of the company's shares.
COFCO Capital: Shareholders intend to reduce their holdings of no more than 3% of the company's shares
COFCO Capital announced that shareholder Hony Hongliang intends to reduce its stake in the company by no more than 3%.
Guangting Information: SAIC Venture Capital intends to reduce its stake in the company by no more than 4%.
Kotei Information announced that shareholder SAIC Venture Capital intends to reduce its stake in the company by no more than 4%.
Jinchuang Group: China Rail plans to reduce its stake by no more than 6%.
Jinchuang Group announced that its shareholder China Rail intends to reduce its holding of no more than 47,023,100 shares, that is, no more than 6% of the company's total share capital.
Kanghua Biologics: Shareholders intend to reduce their holdings by no more than 6%.
Kanghua Biotech announced that Qingdao Yingke, a shareholder of the company, and its concerted actor Tiger Yingke intend to reduce their holdings of the company's shares by a total of no more than 6% of the company's total share capital.
Senba Sensing: Yingbei Investment intends to reduce its stake by no more than 3%.
Yingbei Investment, a shareholder, intends to reduce its holdings by no more than 8.1 million shares, i.e. no more than 3% of the company's total share capital.
South China Instruments: Shareholders intend to reduce their holdings by no more than 1.86%.
South China Instruments announced that shareholders Li Yuan and Xiao Zemin intend to reduce their holdings of the company's shares to no more than 1.86% of the company's total share capital.
Alto Electronics: The actual controller intends to reduce its holding of no more than 1.92% of the shares
Alto Electronic announced that Wu Hanqu, the controlling shareholder and actual controller, intends to reduce his holding of no more than 12.5 million shares of the company, that is, no more than 1.9185% of the company's total share capital.
Desay SV: The controlling shareholder intends to reduce its holdings by no more than 2%.
Desay SV announced that its controlling shareholder, Hui Venture Capital, intends to reduce its holdings by no more than 11.1 million shares, that is, no more than 2% of the company's total share capital.
Aerospace Engineering: Shareholders intend to reduce their holdings in the company
Aerospace Engineering announced that Guochuang Fund, a shareholder holding 9.85% of the shares, intends to reduce its holdings of no more than 16.0797 million shares through centralized bidding and block trading, accounting for 3% of the company's total share capital; The New Car Fund, a shareholder holding 4% of the shares, intends to reduce its holdings of no more than 21.42 million shares through centralized bidding and block trading, accounting for about 4% of the company's total share capital.
Kun Heng Shunwei: Shareholders intend to reduce their holdings of no more than 1% of the company's shares
Kun Heng Shunwei announced that Wu Jiangnian, a shareholder holding 20.64% of the shares, intends to reduce his holdings of the company's shares through centralized bidding or block trading, with a total reduction of no more than 840,000 shares, accounting for no more than 1% of the company's total share capital.
Hongyu shares: Lv Jian intends to reduce his holdings of no more than 2% of the company's shares
Hongyu announced that shareholder Lv Jian intends to reduce his holding of no more than 2% of the company's shares.
【Other matters】
Zhongbei Communications: Signed a framework agreement for the supply of battery systems for motorcycles of 511 million yuan
Zhongbei Communications announced that the company signed a framework agreement on the procurement and supply of motorcycle battery systems with Hangzhou Cycling Technology Co., Ltd., Guangdong Xiaobin Network Technology Co., Ltd., Zhejiang Quxuan Technology Co., Ltd., Guangdong Gongsheng Network Technology Co., Ltd., and Yunnan Lingling Network Technology Co., Ltd. (hereinafter referred to as "Party A"), and Party A plans to purchase lithium iron phosphate battery 48V23AH series products from the company as battery units for motorcycle energy system solutions, purchasing a total of 350,000 sets of 48V23AH battery packs. A total of $511 million.
Humanwell-being Pharmaceutical: Midazolam injection obtained the approval notice of drug supplement application
Renfu Pharmaceutical announced that Yichang Renfu, a holding subsidiary, recently received the "Drug Supplement Application Approval Notice" for the new specifications of midazolam injection approved and issued by the State Medical Products Administration. Midazolam injection is mainly used for preoperative sedation/anxiolytic/amnesia; diagnosis, treatment, endoscopic surgery; induction and maintenance of general anesthesia; Sedation in endotracheal intubation, mechanically ventilated patients, and critical care care.
Sinopharm Hyundai: A wholly-owned subsidiary obtained the drug registration certificate of oplinone hydrochloride injection
Sinopharm Modern announced that Sinopharm Rongsheng, a wholly-owned subsidiary, received the "Drug Registration Certificate" of oplinone hydrochloride injection approved and issued by the State Medical Products Administration. Oplinone hydrochloride injection is suitable for short-term intravenous treatment of acute heart failure that does not respond well to other drugs.
Yuandong Biotechnology: Arolol hydrochloride tablets obtained the "Drug Registration Certificate"
Yuandong Biotech announced that it recently received the "Drug Registration Certificate" of arolol hydrochloride tablets approved and issued by the State Food and Drug Administration, the main indications of the drug are essential hypertension (mild-moderate), angina, tachyarrhythmia, essential tremor. Obtained the drug registration certificate of neostigmine methylsulfate injection, the main indication of the drug is anticholinesterase drug.
Heavy Medicine Holdings: The holding subsidiary obtained the drug registration certificate of olmesartan cilexetil tablets
Heavy Medicine Holdings announced that its holding subsidiary, Heavy Medicine, recently received the "Drug Registration Certificate" of olmesartan cilexetil tablets approved and issued by the State Food and Drug Administration. Olmesartan cilexetil tablets are suitable for the treatment of hypertension, angiotensin II receptor antagonists (ARB), and are the first-line antihypertensive drugs recommended by the expert consensus group on stroke prevention and treatment.
Hokuriku Pharmaceutical: Pramipexole hydrochloride sustained-release tablets generic drug passed consistency evaluation
Hokuriku Pharmaceutical announced that the company received the "Drug Registration Certificate" of two specifications of pramipexole hydrochloride sustained-release tablets issued by the State Food and Drug Administration, and the pramipexole hydrochloride sustained-release tablets were approved according to the 4 categories of chemical drugs, which is deemed to have passed the consistency evaluation of the quality and efficacy of generic drugs. Pramipexole hydrochloride extended-release tablets can be used to treat signs and symptoms of idiopathic Parkinson's disease in adults.
Zhongnan Construction: The cumulative contract sales amount in the first half of the year was 24.68 billion yuan, a year-on-year decrease of 25.2%
Zhongnan Construction announced that in terms of real estate business, the contract sales amount in June was 4.87 billion yuan, with a sales area of 399,000 square meters. From January to June, the cumulative contract sales amount was 24.68 billion yuan, and the sales area was 2.071 million square meters, down 25.2% and 22.6% year-on-year, respectively. In the construction business, 24 new projects were undertaken in June, with an estimated total contract value of 1.13 billion yuan. From January to June, the estimated contract amount of new projects will be 2.11 billion yuan, a year-on-year decrease of 16.9%.
China Railway Construction: Recently won a total bid of 53.653 billion yuan for projects
CRCC announced that the company recently won bids for 8 major projects, with a total project amount of 53.653 billion yuan, accounting for 4.89% of the company's audited operating income in 2022.
Weining Health: The actual controller was placed on file for investigation and liuzhi on suspicion of bribery
Weining Health announced that the company received the "Notice of Case Registration" and "Notice of Liuzhi" from the Maoming Supervision Commission on July 5, and Zhou Wei, the actual controller and chairman of the company, was placed on file for investigation and lien for suspected bribery. The company has a sound governance structure and business processes, the daily operation and management is the responsibility of the company's senior management team, the company's senior management team has made proper arrangements for related matters, and the company is currently operating normally.
Fulongma: Won the bid for a 624 million yuan integrated waste treatment concession project
Fulongma announced that it recently received the "Winning Bid (Transaction) Notice" issued by Guangzhou International Engineering Consulting Co., Ltd., and the company won the bid for the urban and rural integrated waste treatment concession project in Shixing County, Guangdong Province, with a total project amount of 624 million yuan.
East Sunshine: The holding subsidiary obtained a mining license
East Sunshine announced that Shixi Coal Industry, a holding subsidiary, recently obtained the "Wenbishan-Wayaoping Coal Mine Mining License in Tongzi County, Guizhou Province" issued by the Department of Natural Resources of Guizhou Province, the coal mine has a coal resource of 72.52 million tons, and the coal type is mainly poor coal (it is a bituminous coal with the highest degree of coalization, which does not produce colloids when heated, so it is called poor coal), which is mainly used for power and civil fuel.
First shares: 5.88 billion yuan signed in June
In June, the company achieved a total signed area of 185,900 square meters and a signed amount of 5.88 billion yuan. From January to June 2023, the company achieved a total contracted area of 1,308,900 square meters, a year-on-year decrease of 9.4%; The signed amount was 34.937 billion yuan, a year-on-year decrease of 19.66%.
Smooth withdrawal: The company's shares were delisted on July 6
Successfully withdrew announcement, the company's shares have been decided by the Shenzhen Stock Exchange to terminate the listing and will be delisted on July 6.
Shuanghuan transmission: It is planned to invest no more than 120 million euros in the construction of a production base in Hungary
Shuanghuan Transmission announced that the company intends to invest in the construction of a new energy vehicle gear transmission parts production base in Hungary through its subsidiary, with a total planned investment of no more than 120 million euros, including but not limited to land purchase, plant purchase, new plant construction, equipment procurement and other related aspects of the Hungarian company.
Zhongsheng Pharmaceutical: The subsidiary obtained the registration certificate of carbocisteine oral solution
Zhongsheng Pharmaceutical announced that Guangdong South China Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary, recently received the "Drug Registration Certificate" of carboxycilastan oral solution approved and issued by the State Food and Drug Administration. Carbosteine oral solution is used for the treatment of patients with viscous sputum and difficulty in coughing up sputum caused by chronic bronchitis, bronchial asthma and other diseases, and is a class B drug in the medical insurance list.
China's nuclear power: new energy power generation in the first half of the year increased by 62.01% year-on-year
China Nuclear Power announced that as of June 30, the company's cumulative commercial power generation capacity was 100.827 billion kWh, a year-on-year increase of 5.83%; The electricity on the grid was 94.860 billion kWh, a year-on-year increase of 6.11%. Among them, the company's new energy power generation accumulated 10.559 billion kWh, a year-on-year increase of 62.01%; The new energy on-grid electricity was 10.381 billion kWh, a year-on-year increase of 61.92%.
Makihara shares: pig sales revenue in June was 8.689 billion yuan
Makihara announced that in June, the company sold 5.314 million pigs, with sales revenue of 8.689 billion yuan. In June, the company's commercial pig price showed a downward trend compared with May 2023, and the average sales price of commercial pigs was 13.82 yuan/kg, down 2.54% from May 2023.
Great Wall Motor: 26,700 NEV sales in June
Great Wall Motor announced that it sold a total of 105,000 units in June, a year-on-year increase of 3.73%; NEV sales in June were 26,700 units, and the cumulative sales from January to June were 93,200 units.
Nanling Minbao: The abbreviation of the company's securities was changed to "Ipuli"
Nanling Minbao announced that the abbreviation of the company's securities was changed to "Ipuli", and the activation time was July 6, 2023.
Guangyu Development: The subsidiary obtained the construction index of 13 million kilowatts of new energy projects in Xinjiang
Guangyu Development announced that subsidiaries Xinjiang Dabancheng Guangheng New Energy Co., Ltd., Urumqi Zhongludian New Energy Co., Ltd., Kuitun Zhongludian New Energy Co., Ltd., Nileke County Zhongludian New Energy Co., Ltd. and Ruoqiang County Zhongludian New Energy Co., Ltd. filed a total of 13 million kilowatts of new energy projects in Xinjiang.
Tianyu Co., Ltd.: The subsidiary obtained the registration certificate of febuxostat tablets
Tianyu announced that the company's wholly-owned subsidiary, Nord Pharmaceutical, recently received the "Drug Registration Certificate" for febuxostat tablets approved and issued by the State Food and Drug Administration. Febuxostat tablets are indicated for long-term treatment of hyperuricemia in patients with gout.
Nasda: Plans to invest USD 289 million to establish a wholly-owned subsidiary in Hong Kong
Nasda announced that the company or its subsidiaries intend to invest US$289 million to establish a wholly-owned subsidiary, Nasda Reliance Limited, in Hong Kong.
West China Energy: Plans to transfer 100% equity of Zhaotong Environmental Protection for 100 million yuan
West China Energy announced that the company intends to transfer 100% of the equity held by Zhaotong Environmental Protection to Everbright Environmental Protection for a transaction amount of 100 million yuan.
Zhengwei New Material: The subsidiary signed a sales contract for wind turbine blades
Zhengwei New Materials announced that its wholly-owned subsidiary Jiuding New Materials signed a procurement contract with Jiangyin Vision Investment Co., Ltd., and Jiangyin Vision Investment Co., Ltd. and its affiliates purchased wind turbine blades from Jiuding New Materials. The contract is a long-term sales order, and the total contract transaction amount is expected to be 800 million yuan in 2023, and the specific transaction amount is subject to the final transaction amount.
Pulutong: The subsidiary and Zhejiang Tsinghua Yangtze River Delta Research Institute jointly established a R&D center
Pulutong announced that the subsidiary and Zhejiang Tsinghua Yangtze River Delta Research Institute jointly established the "Zhejiang Tsinghua Yangtze River Delta Research Institute-Puyu Times New Energy Storage System Engineering Technology Joint R&D Center".
GAC Group: NEV sales up 96.5% y/y in June
GAC Group announced that total vehicle sales in June were 236199 units, a year-on-year increase of 0.77%, of which 52,544 new energy vehicles were sold, a year-on-year increase of 96.50%.
Lier Chemical: Matters related to the equity reform of controlling shareholders are planned to be launched
Lier Chemical announced that the company once again received the "Notification Letter" from the controlling shareholder Jiuyuan Group on equity reform: Jiuyuan Group currently holds 23.78% of the company's equity and is the largest shareholder of the company, according to relevant national policies and combined with the actual situation of the unit, the shareholder of Jiuyuan Group, China Academy of Engineering Physics, decided to start the equity reform of Jiuyuan Group, which may lead to a change in the controlling shareholder of Jiuyuan Group, resulting in a change in the actual controller of the company. However, this matter will not lead to a change in the controlling shareholders of Lier Chemical, and will not have a significant impact on the company's daily production and operation activities.
Shanghai Ailu: Holding subsidiary signed a letter of intent for strategic cooperation
Shanghai Ailu announced that the company's holding subsidiary, Ailu New Energy, and Wuxi Suntech Solar Power Co., Ltd. (hereinafter referred to as "Suntech Power") signed a strategic cooperation letter of intent, and Ailu New Energy and Suntech Power will carry out strategic and in-depth cooperation from September 1, 2023 to August 30, 2026 to strengthen the development cooperation of both parties in the field of photovoltaic materials. During the above-mentioned cooperation period, iLu New Energy will supply Suntech Power's cost-effective photovoltaic module products in the industry, and Ailu New Energy will provide Suntech Power's reasonable account period, priority production and delivery plan, and the most favorable product price in the supplier system.
Yisheng Pharmaceutical: Zhenyuan capsules were selected for the national collection of proprietary Chinese medicines
Yisheng Pharmaceutical announced that on July 5, the National Joint Procurement Office of Chinese Proprietary Medicines issued the National Procurement Announcement of the National Alliance of Proprietary Chinese Medicines (No. 4), and the company's product Zhenyuan capsules were selected for this centralized procurement. The selected price is 29 yuan / box (the average reduction rate of all products in the national collection of proprietary Chinese medicines is 49.36%, and the reduction rate of Zhenyuan capsules is 14.5%). Up to now, the sales revenue of Zhenyuan capsules accounts for a high proportion of the company's overall revenue.
This article originated from the financial world
![Who else is impressed by the former French international 🇫🇷 Dominique Dropsy? I found this one today when I looked up the information[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)